Related Experiment Video

Updated: Sep 28, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Hematological abnormalities in inborn errors of metabolism--how frequent are they? The Cretan experience

Athanasios Evangeliou1, Eugene Dafnis, Chrisoula Perdikoyanni

  • 1Department of Pediatrics, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece. evangeli@med.uoc.gr

Pediatric Hematology and Oncology
|December 19, 2002
PubMed

Insights

Hematological findings are often overlooked in diagnosing inborn errors of metabolism (IEM). Recognizing these signs can improve early detection and management of IEM patients.

Area of Science:

  • Medical Genetics
  • Hematology
  • Pediatric Medicine

Background:

  • Inborn errors of metabolism (IEM) are a group of genetic disorders.
  • Hematological findings are not commonly associated with IEM diagnosis.
  • Early diagnosis of IEM is crucial for effective management.

Purpose of the Study:

  • To determine the frequency and types of hematological findings in patients with inborn errors.
  • To explore the diagnostic utility of hematological findings in IEM.
  • To highlight the importance of hematological assessment in IEM.

Main Methods:

  • Retrospective analysis of 132 referred patients.
  • Identification and categorization of hematological findings.
  • Correlation of hematological findings with confirmed IEM diagnoses.

Main Results:

  • Hematological findings were present in 31 of 132 subjects.
  • Inborn errors of metabolism (IEM) were confirmed in 21 subjects.
  • Twelve of the 21 IEM patients had associated hematological findings.

Conclusions:

  • Hematological findings represent an underutilized diagnostic marker for IEM.
  • Collaboration between primary care physicians, neurologists, and hematologists can enhance IEM diagnosis.
  • Increased awareness of hematological signs in IEM is recommended for improved patient outcomes.

More Related Videos

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...